48 results on '"Uijl, Estrellita"'
Search Results
2. Perivascular Adipose Tissue in Vascular Function: Does Locally Synthesized Angiotensinogen Play a Role?
3. Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease
4. Interference With the Renin–Angiotensin System (RAS): Classical Inhibitors and Novel Approaches
5. Angiotensin–neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
6. Targeting angiotensinogen with RNA-based therapeutics
7. Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
8. Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen
9. Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
10. Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen
11. Fludrocortisone Induces Aortic Pathologies in Mice
12. BLOOD PRESSURE-INDEPENDENT RENOPROTECTION IN DIABETIC RATS TREATED WITH SMALL INTERFERING RNA TARGETING LIVER ANGIOTENSINOGEN
13. Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
14. Fludrocortisone Induces Aortic Pathologies in Mice
15. Angiotensinogen Suppression:A New Tool to Treat Cardiovascular and Renal Disease
16. Blood pressure-independent renoprotection in diabetic rats treated with small interfering RNA targeting liver angiotensinogen
17. From ARB to ARNI in Cardiovascular Control
18. Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes.
19. Cardiac Angiotensin II Is Generated Locally by ACE and Not Chymase
20. Fifty years of research on the brain renin–angiotensin system: what have we learned?
21. Perivascular Adipose Tissue in Vascular Function:Does Locally Synthesized Angiotensinogen Play a Role?
22. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease
23. DOCA-SALT DIMINISHES BRAIN RAS ACTIVITY IN PARALLEL WITH PLASMA AND RENAL RAS ACTIVITY – NO EVIDENCE FOR SELECTIVE BRAIN RAS ACTIVATION
24. Brain angiotensin suppression in the DOCA-salt model: reversal by angiotensinogen small interfering RNA?
25. CONTROL OF ANTIHYPERTENSIVE EFFECT MEDIATED BY SMALL INTERFERING RNA TARGETING ANGIOTENSINOGEN
26. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease
27. Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
28. No evidence for brain renin–angiotensin system activation during DOCA-salt hypertension
29. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats
30. Abstract P2031: Control Of Antihypertensive Effect Of Small Interfering RNA Targeting Angiotensinogen
31. Abstract P2030: DOCA-Salt Diminishes Brain RAS Activity In Parallel With Plasma And Renal RAS Activity - No Evidence For Selective Brain RAS Activation
32. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
33. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.
34. Targeting angiotensinogen with RNA-based therapeutics.
35. A3941 Long-lasting small interfering RNA targeting angiotensinogen induces a robust and durable antihypertensive effect
36. A3938 Renal angiotensin generation depends on hepatic angiotensinogen (AGT)
37. Abstract P156: Toll-Like Receptor 2 Deficiency Exacerbates Deoxycorticosterone Acetate-Salt-Induced Hypertension
38. Abstract P110: Renal Angiotensin Generation Depends on Hepatic Angiotensinogen: Evidence From a Preclinical Study With RNAi Therapeutics Targeting Liver Angiotensinogen
39. Abstract 079: Long-Lasting RNAi Therapeutics Targeting Angiotensinogen Induces a Robust and Durable Antihypertensive Effect
40. Angiotensin generation in the brain: a re-evaluation
41. Neprilysin inhibition and endothelin-1 elevation: Focus on the kidney
42. Renin–Angiotensin–Aldosterone System Parameters as Biomarker in Heart Failure Patients With Preserved Ejection Fraction: Focus on Angiotensinogen
43. Abstract P139: Dual Angiotensin Receptor and Neprilysin Inhibition Improves Renal Hemodynamics and Reduces Kidney Damage in Diabetic Rats
44. Brain Renin–Angiotensin System
45. Abstract P278: On the Origin of Brain Renin
46. PS 16-13 ON THE ORIGIN OF BRAIN RENIN
47. Renin-Angiotensin-Aldosterone System Parameters as Biomarker in Heart Failure Patients With Preserved Ejection Fraction: Focus on Angiotensinogen.
48. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.